Back

Disc Medicine says DISC-3405 cut phlebotomy events in Phase 2 PV study

Verifying
  • Disc Medicine reported initial RESTORE-PV results for investigational DISC-3405 in polycythemia vera patients.
  • 4.0 baseline events fell to 0.6 after 26 weeks among 13 Cohort A participants.
  • Disc Medicine plans additional RESTORE-PV and sickle-cell data by the end of 2026.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.